Healthcare tech company Omnicell (NASDAQ:OMCL) announced in Q2 CY2025, with sales up 5% year on year to $290.6 million. On top of that, next quarter’s revenue guidance ($295 million at the midpoint) ...

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2025 results , with sales up 9.6% year on year to $269.7 million. On the other hand, next quarter’s revenue guidance of $275 million was ...

Omnicell's service business is rapidly growing, now 22% of revenue, outpacing industry trends and supporting long-term upside. My updated DCF analysis yields a price target of $57.46, representing 93% ...

Results exceed previously issued first quarter 2025 guidance for total revenues and non-GAAP EPS Updates full year 2025 non-GAAP EBITDA and non-GAAP EPS guidance Omnicell, Inc. (NASDAQ:OMCL) ...

FORT WORTH, Texas (AP) — FORT WORTH, Texas (AP) — Omnicell Inc. (OMCL) on Thursday reported profit of $5.6 million in its second quarter. On a per-share basis, the Fort Worth, Texas-based company said ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ: OMCL) (“Omnicell”) today announced the pricing of $150.0 million aggregate principal amount of 1.00% Convertible Senior Notes due 2029 (the ...